European Medicines Agency Updates Seasonal Flu Vaccine Guidance - - BioPharm International

ADVERTISEMENT

European Medicines Agency Updates Seasonal Flu Vaccine Guidance


The European Medicines Agency released an update to its guidance for the annual strain change of influenza vaccines to reflect current knowledge. The change makes the guidance document consistent with the approach taken by other global regulatory authorities. An improved system that allows strengthened and sustainable monitoring of an influenza vaccine’s performance over the years in a real-life setting is introduced in the guidance.

The guidance states that vaccine manufacturers will be required to submit for each vaccine appropriate measures for proactive surveillance of the safety and effectiveness to regulatory authorities for review. The requirement is for the influenza season 2014-2015 onwards. With the new system in place, EMA will no longer require routine submission of clinical trials for annual strain-change updates. An interim guidance will be published by March 2014 and will address the principles of safety monitoring commitments that should form part of the proactive surveillance.

Source: European Medicines Agency

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines

Click here